Clinical trial
Recording ESR1 Mutations in Metastatic Hormone Receptor-Positive Breast Cancer in the Greek Population: A Non-Interventional, Retrospective and Prospective Observational Study of Clinical Practice Data and Treatment Utilization Patterns in Routine Care
NCT07899463 is registered in ClinicalTrials.gov with Hellenic Cooperative Oncology Group as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, 14-day trial. Card required. Your first charge is when the trial ends. See pricing
Registry record
As filed in ClinicalTrials.gov.
- Title
- Recording ESR1 Mutations in Metastatic Hormone Receptor-Positive Breast Cancer in the Greek Population: A Non-Interventional, Retrospective and Prospective Observational Study of Clinical Practice Data and Treatment Utilization Patterns in Routine Care
- Lead sponsor
- Hellenic Cooperative Oncology Group
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- May 13, 2025
- Completion date
- October 15, 2027
- Enrollment
- 500 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
breast cancer (locally advanced or metastatic), esr1 gene mutation, hormon receptor positive breast cancer
Arms
As registered; 1 arm.
-
Metastatic HR+ Breast Cancer ESR1 Cohort
Patients with metastatic HR-positive/HER2-negative breast cancer in Greece who have been tested for ESR1 mutations. Data collected include ESR1 mutation status (via NGS liquid biopsy), clinicopathological features, and treatment patterns in routine clinical practice. No changes to standard therapy are required, and data collection occurs only during routine clinical visits
Primary endpoints
Registered primary outcome measures; 1 primary.
-
Prevalence of ESR1 mutations
The proportion of patients with metastatic HR+/HER2- breast cancer in Greece who have detectable ESR1 mutations, determined by next-generation sequencing (NGS) of circulating tumor DNA (liquid biopsy) among all patients tested. Data are collected retrospectively and prospectively from routine clinical visits.
Lead sponsor's other trials
Hellenic Cooperative Oncology Group, most recent start first.
+56 more trials See the organization page
Similar trials
Same condition (Neoplasm Metastasis) and phase, most recent start first.
+442 more trials See the condition page